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The effect of Progressive Muscle Relaxation on Daily Cortisol Secretion
Abbreviated Progressive Muscle Relaxation (APMR) is a shortened version of 
Jacobson’s (1939) original technique, designed to induce feelings of deep relaxation by 
systematically tensing and relaxing 16 muscle groups and by learning to focus on and 
discriminate between the resulting sensations of tension and relaxation (Bernstein & Borkovec 
1973).  There is empirical evidence of APMR’s efficacy in reducing negative states of anxiety 
and perceived stress (Emery et al. 2008; Rausch, Gramling & Averbach 2006), and increasing 
positive feeling of relaxation (Pawlow & Jones 2002) as well as producing clinically significant 
improvement of tension headache in a randomized placebo controlled clinical trial  (Blanchard 
et al. 1990).
The question addressed here is not therefore about its efficacy relative to non-
intervention in reducing psychological stress.  Rather, we ask whether a fully expected 
reduction in psychological stress will be matched by equivalent physiological stress-reduction.  
In assessing APMR’s capacity to manage stress defined as a more holistic psychosomatic 
construct, this study has the potential to make an important contribution to research in this area.
The end product of the Hypothalamic-Pituitary-Adrenal (HPA) axis, cortisol is a useful 
but complex biomarker, owing to the need to consider its dynamic diurnal cycle.  Cortisol 
typically rises dramatically to very high levels in the first hour post-awakening, the so-called 
“Cortisol Awakening Response” (CAR), decreasing thereafter (Clow et al. 2004).  There is 
growing evidence that the dynamic changes in this brief CAR period may particularly reflect 
cognitive functioning to meet daily demands and challenges (Evans et al. 2012; Evans et al. 
2011; Fries et al. 2009; Wetherell, Lovell & Smith 2014).  However, the CAR period is 
extremely volatile and presents formidable challenges in terms of its reliable measurement due 
to the need to ensure highly accurate timing of the saliva samples from which cortisol 
concentrations are derived.  Very large changes in cortisol values take place over very small 
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time intervals, which need in turn to be expressed relative to individual awakening times rather 
than clock-time (Smyth et al. 2013a).  In regard to using cortisol as a biomarker of chronic 
stress, use of sample values from the brief volatile CAR period following awakening may 
actually be best avoided (Smyth et al. 2013b; Garcia-Banda et al. 2014).  This is likely to be 
good practice since traditionally chronically higher levels of stress over time have tended with 
reasonable consistency to be linked to higher average levels of total daily cortisol secretion, 
which is clearly determined overwhelmingly by secretion rate outside the very brief CAR 
period (Smyth et al. 2013b).
Cortisol measures have been used before in stress intervention studies.  Most typically, 
such studies (e.g. Dolbier & Rush 2012; Pawlow & Jones 2002; Pawlow & Jones 2005) have 
chosen to examine the acute effects of APMR on ‘spot’ cortisol levels assessed immediately 
before and after brief APMR sessions, sometimes even a single session.  While such findings 
have generally been positive and supportive of APMR efficacy, there is a need to examine 
changes in cortisol measures chosen to provide stable and comparable estimates of average 
cortisol secretion prevailing over a meaningful period of time before and after intervention 
using multiple cortisol sampling over time.  This would more clearly address the efficacy of 
APMR as a useful therapeutic intervention to reduce physiological stress.  At least one study 
provides some supportive evidence of APMR efficacy in this respect (Krajewski et al. 2011) 
but drawing firm conclusions is very significantly limited by its total sample of only 7 
individuals.  Our study is designed to provide much firmer evidence of change which may 
endure beyond intervention, and where intervention itself extends beyond a single short session 
of APMR.
Accordingly, this study examines response to APMR in a sample of first-year university 
students, who were recruited as part of a wider program of research on stress and cortisol.  
Going to university is reportedly a stressful time for at least 50% of students (Regehr, Glancy 
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& Pitts 2013).  Heavy academic demands and the need to forge novel social networks can for 
some be huge stressors (Dolbier & Rush 2012), creating worrying rates anxiety and depression.  
Therefore, apart from convenience, there are reasons that may make this a suitable population 
for this investigation.  We hypothesized that one week of intensive APMR delivered by a 
trained professional would be effective in reducing both psychological and physiological stress.  
Using methodological techniques to ensure accurate timing of cortisol samples, we have sought 
in this study to provide best estimates of total cortisol secretion based on multiple sampling 
over two days, in weeks before and after APMR intervention.  For all such estimates we have 
carefully excluded values within the brief post-awakening period of dramatic rise.
One strand of the wider program of research mentioned above involved exploration of 
detailed cortisol profiles in relation to personality and in particular Neuroticism as a possible 
stress vulnerability trait (Garcia-Banda et al. 2011; Garcia-Banda et al. 2014).  While we had 
no firm hypothesis in this study in regard to the possible modulation of any intervention effects 
by Neuroticism, the availability of these data allowed us to include Neuroticism along with 
sex, age and smoking status in subsidiary analyses to demonstrate if necessary that any obtained 
stress reduction effects were independent of these individual difference variables.
Method
Participants
First year students from the University of Balearic Islands were recruited annually into 
this APMR intervention study over a period of four years from a larger sample of students who 
had already provided psychometric data for research purposes.  Over the course of the four 
years, six groups attended a week’s course of APMR training.  Overall 101 student volunteers 
provided complete data, including saliva samples and attendance at a one-week course of 
APMR relaxation training.  Sixty-six were female.  Mean age was 21.18 years (SD = 5.141).  
For regression analysis purposes, age was best operationalized as a dichotomous variable with 
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a large younger group (n=67) aged 18-20 years, and a smaller tail (N=34) of students older 
than 20 (age range 21-42 years).  In total, 63 were high on Neuroticism and 38 were low (see 
Table 1).
[Table 1 near here]
Intervention
APMR sessions were conducted by an expert and university trainer (third author) in 
this technique who remained blind to collected data until the completion of this study.  The 
APMR was performed following strictly the standard procedures set forth by Bernstein and 
Borkovec (1973).  APMR training consists of five 45 minute session of tensing and releasing 
16 muscle groups (dominant and non-dominant hand and forearm, dominant and non-dominant 
biceps, forehead, upper cheeks and nose, lower cheeks and jaws, neck and throat, chest, 
shoulders and upper back, abdominal or stomach region, dominant and non-dominant thigh, 
calf and foot) designed to produce both cognitive and physiological relaxation.  Instructions 
encouraged participants to focus on sensations associated with release of muscle tension and 
feelings of comfort.  They were advised not to tense muscle groups that felt strained or that 
aggravated pain.
Measures
Neuroticism. At the time of initial recruitment into the wider program of research of 
which this study forms a part, the NEO-FFI (Costa & McCrae 1999) was used to evaluate 
neuroticism using 12-item subscale (score range = 0 to 48).  Participants responded on a 5-
point Likert scale from 0 (totally disagree) to 4 (totally agree).  The internal consistency value 
for our sample was .83.  Participants were pre-selected as being high (> 85th percentile) or low 
(< 15th percentile) on the NEO-FFI Neuroticism scale (Costa & McCrae 1999) and 
Neuroticism was thus analyzed as a dichotomous variable.
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Survey of Recent Life Experiences (SRLE). The SRLE was developed by Kohn and 
McDonald (1992) and covers the following areas: mundane annoyances, domestic 
responsibilities, work, romance, friends, family, other social relationships, finances, 
environment, time pressure, competitive standing (in terms of abilities, attractiveness, etc.), 
and future security.  Participants indicated the extent of their recent life experiences over the 
past month on the following 4-point scale: 1 = not at all part of my life; 2 = only slightly part 
of my life; 3 = distinctly part of my life; and 4 = very much part of my life.  Total SRLE score 
is computed by adding all the values given (1 to 4) to each question (range: 41-164).  The 
internal consistency value for our sample was .93 (original value .90; Khon & McDonald 
1992).
Cortisol. Salivary cortisol measures were collected with a cotton swab chewed for one 
minute, stored in a capped plastic vial (“Salivette” Sarstdet Inc.).  These samples were 
centrifuged at 3000g for 3 minutes, and then the filtrates were stored frozen at -80ºC until 
analysis.  Before analysis, the samples were thawed, mixed, centrifuged and analyzed without 
pre-treatment.  To reduce error, all samples of each participant were analyzed in one assay.  
Salivary cortisol was measured using a modification of the Bayer ADVIA Centaur cortisol 
assay, a competitive direct chemiluminescence’s immunoassay that uses a rabbit polyclonal 
antibody.  Endogenous cortisol contained in the samples competes with a cortisol labeled with 
acridinium-ester for the binding sites of the anti-cortisol rabbit polyclonal antibody-coated 
paramagnetic particles.  The intra- and inter-assay coefficients of variation were less than 10% 
for 0.30 μg/dL of cortisol.
Adherence Electronic Monitoring. Timing cortisol adherence was measured by 
Medication Event Monitoring System (MEMS) Track Caps device (AARDEX, Ltd., Zug, 
Switzerland).  Participants took an absorbent cotton swab at each assigned sampling time from 
a plastic bottle with a microchip lid that recorded the time of each opening.  After collecting a 
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saliva sample, participants stored the swab in a pre-labeled plastic tube (Salivette, Sarstedt, 
Barcelona, Spain) and manually registered the time (e.g., 8:30 am) on the protocol-required 
form everytime they took a saliva sample.  The registered time by hand was then compared 
with the time measured by the MEMS caps, to guarantee that the “subjective” information 
provided by participants was accurate.  An AARDEX interface and software were used to 
transfer time collection from the MEMS to PC (Broderick et al. 2004).  In addition, participants 
programmed their mobiles to beep at the established times in order to further enhance 
compliance.  Discrepancy between MEMS and protocol-required timing of saliva samples 
could thus be used to check the sensitivity of any hypothesized effects to degree of timing 
errors.
Procedure
First year UIB students gave informed consent in their classes.  Those who wanted to 
participate in the study provided their e-mail address and mobile phone number.  In order to 
evaluate the effect of APMR on perceived stress participants completed the SRLE scale the 
week before and after the training.  Cortisol secretion was assessed by collecting five measures 
of cortisol across the day (awakening, 45 min, 2.5h, 8h and 12h), on two days (Tuesday and 
Thursday), one-week before (pre) and one-week after (post) the intervention.  To provide a 
degree of control for the possibility that any cortisol reduction over the course of weeks in the 
main study may have reflected simple habituation over time rather than the intervention, we 
included an additional baseline cortisol measure taken two-weeks prior to the pre-intervention 
in half of the six cohort groups.  Additionally, participants used the MEMS Caps to register 
each time they took a saliva sample.  Moreover, students filled the information protocol 
registering the exact time of each sample, including wake-time (“as soon as you open your eyes 
and before getting up”), eating times, caffeine intake, medication taken, or if they had siesta, 
or they did sport, etc. (see Adam & Kumari 2009).  Participants were not given reimbursement 
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for their participation, although at the end of the study they received detailed information about 
their personality and cortisol profiles. 
Treatment of Data and Statistical Analysis
Outcome measures were examined for normality of distribution.  Extreme outlying 
scores (+/- three-standard deviation) were winsorized and in the case of cortisol were root 
transformed to reduce skewness statistics to approximately twice the standard error or less.
A Total Cortisol Secretion (TCS) measure was calculated as area under the curve 
(AUC) of cortisol measures collected at 0.75h, 2.5h, 8h, and 12h after awakening on Tuesday 
and Thursday for each time period (pre- and post-intervention), using the standard trapezoid 
formula (Pruessner et al. 2003).
Outcome effects were examined using mixed regression modeling (MRM), an approach 
deemed most appropriate for multilevel designs incorporating repeated measures over time 
with fixed and random parameters (Blackwell, Mendes de Leon & Miller 2006).  This approach 
has been used in particular to model dynamic aspects of the diurnal cortisol cycle (Smyth et al. 
2013a), and in this case enabled us to examine over two time periods (pre and post) the effect 
of APMR on SRLE and TCS.  Similar two-level models were constructed for both dependent 
variables.  In each case we assumed random intercepts and random slopes at the first level 
(Model A), which were modelled as outcomes at level 2 (Model B) when between-persons 
covariates were introduced.  The goal in Model B was to determine which person-level 
characteristics might modulate differences at the within-person level.
Model A represents solely within-person effects and included the fixed covariates of 
pre- and post- intervention weeks, wake-time, and, for TCS only, sampling day within weeks 
(Tuesday vs. Thursday).  The dichotomous variable of sampling day was effect coded such that 
zero represented cortisol secretion effects for other variables averaged across both sampling 
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days.  For similar reasons and following convention (Blackwell et al. 2006), wake-time was 
participant-centred such that scores represented the purely within-participant effect of changes 
in wake-time across occasions, with each score computed as a person’s raw wake-time minus 
their own mean wake-time over all four study days.  Thus again a value of zero in the model 
equations would represent conditions in which wake-time was assumed to be average for each 
participant.  Finally the key covariate of the intervention (pre vs. post) was dummy coded (0/1) 
such that 0 (and therefore the intercept in the model) represented SRLE or TCS pre-
intervention.
In Model B, the following level 2 (between-persons) fixed covariates were included: 
sex, age category, smoking status, neuroticism group, and allocation (or not) to an additional 
baseline (pre-intervention) assessment of outcome measures.  All these dichotomous variables 
were effect coded such that -1 represented the category values of female, younger age, non-
smoker, low neuroticism, and absence of additional baseline assessment, and +1 represented 
binary opposites.  A preliminary full Model B was run including all covariates to examine their 
statistically independent effects on baseline (intercept coefficient) levels of dependent 
variables, and all two-way interactions involving intervention (pre-post slope coefficient).  The 
latter test within the model for possible modulation of within-person intervention effects by 
between-persons covariates.  The final Model B presented here involved backward elimination 
of covariates with no significant effects on intercept or intervention slope coefficients.
Results
Full details of all analyses including coefficients for estimating all Model A and final 
Model B effects for both stress measures are given in Table 2.
Effect of APMR on SRLE
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The results of Model A indicate that the intercept (denoting SRLE baseline) before 
APMR training was 72.03.  The slope coefficient (-6.90) for the intervention effect was 
statistically significant (F = 39.88; df = 1, 89.71; p < .001) and is an estimate of the reduction 
in SRLE measured stress in the week following the intervention, with wake-time held at its 
zero (mean) value.  Wake-time was not associated with overall SRLE scores nor with changes 
in SRLE post-intervention.  The final model B yielded similar intercept (69.21) and 
intervention slope (-6.84) values, the latter remaining highly significant (F = 39.98; df = 1, 
89.76; p < .001) and, expressed in percentage terms, the intervention was followed by an 
approximately 10% reduction in SRLE measured stress, equivalent to a Cohen ‘d’ effect size 
of 0.38 (see Figure 1).  Model B yielded a significant (F = 47.44; df = 1, 92.60; p < .001) main 
effect coefficient of 10.74, for neuroticism.  This coefficient estimates that high neuroticism 
participants tended to report 10.74 (approximately 16%) more SRLE stress units than the study 
average, and low neuroticism participants equivalently less.  The Neuroticism x Intervention 
interaction was not significant, so there was no suggestion that Neuroticism modulated the 
main finding of a reduction in SRLE stress following the intervention.  Equally there were no 
other significant main effects on overall level of SRLE stress reporting and no evidence of 
modulation of the significant intervention effect, with all other terms being excluded from the 
final model in the process of process of backward elimination (see Table 2).
[Table 2 near here]
Effect of APMR on Cortisol Secretion
The results of Model A using MRM analysis indicate that average total cortisol 
secretion (TCS) before APMR training (intercept) was 1.055 root units (equivalent to 5.48 
μg/dl).  The estimate of slope coefficient for intervention was -.003 root units (-0.45 μg/dl), (F 
= 6.49; df = 1, 123.45; p < .012).  In this case slope was equal to differences between pre and 
post intervention means, with sampling day and wake-time held at zero (mean) values.  Thus 
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APMR was followed by a significant decrease in cortisol secretion a week after the training.  
Later wake-time was significantly associated (F = 13.91; df = 1, 222.12; p < .001) with lower 
cortisol regardless of time point (pre- or post-intervention) with a significantly negative slope 
coefficient of -.004 in the equation based on root units.  This would translate into a reduction 
of 0.56 μg/dl for every hour that participants might wake up later than their own typical average 
time.  The intervention*wake-time interaction was not significant indicating that the efficacy 
of the intervention in reducing cortisol was not associated with any pre-post changes in wake-
time.  No significant effects were evident involving day of week.
Model B yielded closely similar estimates of intercept and intervention slope to Model 
A indicating a similar degree of significant (F = 6.94; df = 1, 133.78; p < .009) cortisol 
reduction of approximately 8% following the intervention (see Figure 1), and equivalent to a 
Cohen ‘d’ effect size of 0.30.  More detailed descriptive examination of total AUC cortisol 
secretion over the course of the day (excluding secretion before 4 min post-awakening) showed 
that pre-post diminutions in mean secretion rates were consistent across the three post-45 min 
sampling periods (i.e., 45 min – 2.5h, 2.5 – 8h, and 8h – 12h).  Consecutive mean secretion 
rates (ugs/dl/h) were 1.05, 0.49, and 0.29 in the pre-condition, and 0.98, 0.43, 0.27 in the post-
condition.  In both conditions, the same normal diurnal decline in secretion is apparent.  None 
of the level 2 covariates interacted significantly with the intervention covariate, suggesting that 
the degree of cortisol reduction did not depend on gender, age, neuroticism, smoking status or 
whether participants’ baseline cortisol was assessed once or twice before the intervention.  
Regardless of pre or post occasions, males had overall higher levels of cortisol than females (F 
= 4.93; df = 1, 92.07; p < .029), younger students (<21 years) had higher levels of cortisol than 
older ones (F = 9.14; df = 1, 91.44; p < .003), and participants whose baseline cortisol was 
assessed twice before the APMR intervention had significantly lower levels of cortisol than 
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participants who had a single week pre-intervention baseline (F = 44.18; df = 1, 91.32; p< 
.001).
[Figure 1 near here]
Discussion
These results confirm findings from controlled studies that Abbreviated Progressive 
Muscle Relaxation (APMR) can significantly reduce cortisol secretion, suggesting that this 
could be representative of reduced physiological responding to stress psychological stress 
(Emery et al. 2008; Rausch, Gramling & Averbach 2006).  The SRLE was used as a hassles 
measure (Kohn & McDonald 1992) suitable for determining accurately how much stress 
participants have experienced over a short period of time, in this case, one-week.
However the principle aim of this study was to test the hypothesis that improvement in 
the self-report based outcome would be matched by improvement in a stress-relevant 
biomarker, viz. cortisol.  The cortisol measure (TCS) was carefully chosen and constructed to 
ensure its fitness for purpose.  Careful attention was paid to timing accuracy of saliva sampling, 
exclusion of samples in the immediate post-awakening period, and adequate multiple sampling 
during the course of each of four proximal days, two days in each period.  In such 
circumstances, construction of a TCS measure of the kind employed in this study can provide 
a stable estimation of a participant’s prevailing cortisol level over at least the period around the 
sampling days.  Particular emphasis is drawn to the fact that in averaging over more than one 
day, the TCS measure used in this study attenuates the influence of within-day acute cortisol 
responses to situational demands and excludes entirely the influence of within-participant 
fluctuations in the most volatile period of the diurnal cycle which follows awakening.
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Using a robust physiological outcome measure based on accurately timed cortisol 
sampling over multiple days, we were able to confirm our hypothesis that a one-week course 
of APMR decreased significantly students’ levels of cortisol physiological stress one-week 
after the intervention.  In terms of control features of the design, approximately half the 
participants provided stress outcome measures in an additional baseline trial one week before 
the pre-intervention week common to all participants.  If the cortisol reduction between pre- 
and post- intervention sampling found for all participants were due to a simple temporal effect 
reflecting perhaps “habituation” of a temporary cortisol reactivity to the novelty and challenge 
of the saliva collection protocol itself, then the efficacy of the intervention, assessed in terms 
of cortisol, might appear to be significantly less in the sub-group whose post-intervention 
represented their third, as opposed to second, exposure to the saliva collection protocol.  In 
essence, if simple repetition of the cortisol sampling protocol rather than intervention were the 
only factor promoting cortisol reduction over time, then greater cortisol reduction should be 
apparent following intervention in those participants exposed to only one pre-intervention base-
line assessment.  This would be manifested by a significant interaction between presence of 
additional base-line and pre versus post intervention period.  Results showed no significant 
influence of an additional baseline exposure to saliva collection on the efficacy of the 
intervention.  The cohort groups which were selected for additional baseline cortisol 
assessment did have significantly lower cortisol overall (i.e., both pre and post intervention).  
However, simple absolute differences between cohorts, where the cohorts have been recruited 
and the cortisol assayed over a significant course of time, as in this study design, are not 
unexpected.  As is the case when differing average values pertain for equivalent studies from 
different laboratories, such differences in absolute cortisol values cannot readily be interpreted.
Another variable which was examined and statistically controlled in this study was wake-
time.  Later wake-time was significantly associated with lower cortisol secretion.  People who 
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woke up later had lower cortisol secretion compared with people who woke up earlier.  Wake-
time effects on cortisol secretion levels have been reported before in the psychophysiology 
literature (Edwards et al. 2001; Kudielka & Kirschbaum 2003; Okun et al. 2010).  However 
the crucial finding, in terms of the focus of this paper, was that the intervention effect was 
independent of wake-time.  In other words there was no evidence that the efficacy of the APMR 
in reducing TCS was mediated by any changes in wake-time between pre- and post-
intervention.  Equally, no modulating role was found for neuroticism and APMR was equally 
effective in reducing stress measures in both high and low neuroticism groups.  Sex, age, and 
smoking status were not related to psychological stress.  However, sex and age effects were 
apparent for cortisol measures.  Male and younger people presented higher levels of TCS, 
which is in line with the results found by Seeman et al. (2001).  However none of these variables 
in any way modulated the pattern of cortisol stress reduction apparent over the trial period for 
all participants.
Despite its strengths, this study does have some limitations.  Our principal aim was to 
demonstrate dual impact of APMR on both psychological and physiological stress.  As reported 
in the introduction, against non-intervention control conditions, efficacy of APMR in relation 
to improvement in self-reported or observed symptomology has already been established in the 
existing literature.  Nevertheless, we should issue a caveat that our study was not intended to 
be a randomized controlled trial of APMR efficacy and inappropriate conclusions should not 
be drawn in this regard.  Of interest here was the examination of intervention effects in the 
student population and there must be caution in generalizing from a basically healthy and 
young adult population to more “distressed” populations across the fuller adult age range.  Such 
populations may be more difficult to investigate with the same degree of experimental control 
but they may also be deemed more in need of therapeutic intervention.  Longer follow-up would 
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also be desirable to demonstrate if enduring gains might indicate the extent to which a “life-
skill” has been acquired from this relatively short and cost-effective intervention.
Conclusions
First, this study suggests that APMR is an effective intervention to decrease both 
perceived stress and cortisol secretion, particularly in university students, maintaining these 
changes a week after the training.  Efficacy effects were independent of individual differences 
in wake-time, neuroticism, sex, age and smoking status.  Thus, given the high rates of stress-
related mental health problems reported by students (Regehr, Glancy & Pitts 2013), university 
health services may wish to consider the benefits of making this type of intervention more 
widely available as a means of combating student stress and possibly helping to lower the 
incidence of more serious resultant anxiety and depression (Bewick et al. 2010).  Relaxation 
training might offer real benefits to students as they seek to cope with the challenges of their 
degree journey.  Secondly this study suggests that cortisol as a bio-measure of stress could 
provide a useful and informative addition to self-report outcome measures in evaluating a range 
of interventions in the area of stress management.  However ensuring appropriate, reliable and 
robust cortisol measurement does involve addressing some complex issues, which are treated 
in more detail elsewhere (Smyth et al. 2013b).
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Table 1
Sample characteristics in relation to baseline cortisol assessment
Groups
Additional baseline Single baseline
Characteristics n % n %
Neuroticism
Low-N 19 41.3% 19 34.5%
High-N 27 58.7% 36 65.5%
Age
Younger 26 56.5% 41 74.5%
Older 20 43.5% 14 25.5%
Gender
Female 32 69.6% 34 61.8%
Male 14 30.4% 21 38.2%
Smoking status
Non-smoker 32 69.6% 44 80%
Smoker 14 30.4% 11 20%
Total 46 45.5% 55 54.5%
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Table 2
Effects of the intervention on the two outcome variables
Model A Final Model B
SRLE Coeff (SE) p< Coeff (SE) p<
Fixed effects
Intercept 72.03 (1.91) .001 69.21 (1.60) .001
Intervention -6.90 (1.12) .001 -6.84  (1.1) .001
Wake-time 1.22 (3.39) .719
Intervention*Wake-time -2.00 (6.16) .746
Neuroticism 10.74 (1.52) .001
Variance (SD) p< Variance (SD) p<
Random effects
Level 1 residual 58.86 (86.00) .001 52.71 (180.10) .003
Intercept 289.9 (460.8) .001 183.7 (309.30) .001
Linear slope 10.52 (325.50) .747
TCS Coeff (SE) p< Coeff (SE) p<
Fixed effects
Intercept 1.050 (.001) .001 1.055 (.001) .001
Intervention -.003 (.001) .012 -.003 (.001) .009
Day -.001 (.001) .444
Intervention *Day -.001 (.001) .532
Wake-time -.004 (.001) .001 -.004 (.001) .001
Intervention*Wake-time -.000 (.002) .855
Additional baseline -.007 (.001) .001
Gender .003 (.001) .029
Age -.003 (.001) .003
Variance (SD) p< Variance (SD) p<
Random effects
Level 1 residual .000107 (.00011) .001 .000107 (.00011) .001
Intercept .000138 (.00024) .001 .000083 (.00017) .001
Linear slope .000001 (.00019) .523 .000014 (.00017) .432
Note. SE = standard error; SD = standard deviation; TCS = total cortisol secretion.
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Figure 1. Effect of abbreviated progressive muscle relaxation (APMR) intervention on 
psychological stress measured by the survey of recent life events (SRLE) and total cortisol 
secretion (TCS) following the final Model B. 
* p < .001 
